Business
DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24
DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24
About this update from Dimerix Limited
[{"type":"text","content":"Dimerix Ltd has released a press release. View Attachment","length":227,"tagName":"div"}]